Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis

Journal of Allergy and Clinical Immunology

Volumn 117, Issue 1, 2006, Pages 134-140

  Casale, Thomas B ^a   Busse, William W ^b   Kline, Joel N ^c   Ballas, Zuhair K ^d   Moss, Mark H ^b   Townley, Robert G ^a   Mokhtarani, Masoud ^d   Seyfert Margolis, Vicki ^d   Asare, Adam ^d   Bateman, Kirk ^e   Deniz, Yamo ^f  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d Immune Tolerance Network   (United States)

^e Pharmaceutical Product Development   (United States)

^f GENENTECH INC   (United States)

Author keywords

Allergy; Clinical trial; IgE; IgG; Immunotherapy; Omalizumab; Ragweed; Rhinitis

Indexed keywords

IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; OMALIZUMAB; PLACEBO; RAGWEED ANTIGEN;

ABDOMINAL PAIN; ADULT; ALLERGIC REACTION; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIGEN SPECIFICITY; ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLUSHING; HAY FEVER; HUMAN; HYPOTENSION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PARALLEL DESIGN; POST HOC ANALYSIS; PREMEDICATION; PRIORITY JOURNAL; PRURITUS; RAGWEED; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; RUSH IMMUNOTHERAPY; SCORING SYSTEM; SIDE EFFECT; SYSTEMIC DISEASE; TREATMENT OUTCOME; URTICARIA; WHEEZING;

ADOLESCENT; ADULT; AMBROSIA; ANTIBODIES, MONOCLONAL; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; RHINITIS, ALLERGIC, SEASONAL;

EID: 29544443510     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2005.09.036     Document Type: Article

References (35)

1. T.B. Casale Status of immunotherapy: current and future J Allergy Clin Immunol 113 2004 1036 1039
2. P.S. Norman Immunotherapy: past and present J Allergy Clin Immunol 102 1998 1 10
3. P.S. Norman Immunotherapy: 1999-2004 J Allergy Clin Immunol 113 2004 1013 1023
4. S.J. Till, J.N. Francis, K. Nouri-Aria, and S.R. Durham Mechanisms of immunotherapy J Allergy Clin Immunol 113 2004 1025 1034
5. S.R. Durham, S.M. Walker, E.M. Varga, M.R. Jacobson, F. O'Brien, and W. Noble Long-term clinical efficacy of grass-pollen immunotherapy N Engl J Med 341 1999 468 475
6. R.A. Des, L. Paradis, J.L. Menardo, S. Bouges, J.P. Daures, and J. Bousquet Immunotherapy with a standardized Dermatophagoides pteronyssinus extract, VI: specific immunotherapy prevents the onset of new sensitizations in children J Allergy Clin Immunol 99 1997 450 453
7. C. Moller, S. Dreborg, H.A. Ferdousi, S. Halken, A. Host, and L. Jacobsen Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study) J Allergy Clin Immunol 109 2002 251 256
8. B.E. Garcia, M.L. Sanz, J.J. Gato, J. Fernandez, and A. Oehling IgG4 blocking effect on the release of antigen-specific histamine J Investig Allergol Clin Immunol 3 1993 26 33
9. P.A. Wachholz, N.K. Soni, S.J. Till, and S.R. Durham Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy J Allergy Clin Immunol 112 2003 915 922
10. Allergen immunotherapy: a practice parameter American Academy of Allergy, Asthma and Immunology. American College of Allergy, Asthma and Immunology Ann Allergy Asthma Immunol 90 2003 1 40
11. D.I. Bernstein, M. Wanner, L. Borish, and G.M. Liss Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001 J Allergy Clin Immunol 113 2004 1129 1136
12. T. Lower, J. Henry, L. Mandik, J. Janosky, and G.A. Friday Jr. Compliance with allergen immunotherapy Ann Allergy 70 1993 480 482
13. D. Tinkelman, F. Smith, W.Q. Cole III, and H.J. Silk Compliance with an allergen immunotherapy regime Ann Allergy Asthma Immunol 74 1995 241 246
14. R.F. Lockey, G.L. Nicoara-Kasti, D.S. Theodoropoulos, and S.C. Bukantz Systemic reactions and fatalities associated with allergen immunotherapy Ann Allergy Asthma Immunol 87 2001 47 55
15. H.J. Malling Minimising the risks of allergen-specific injection immunotherapy Drug Saf 23 2000 323 332
16. J. Portnoy, K. King, H. Kanarek, and S. Horner Incidence of systemic reactions during rush immunotherapy Ann Allergy 68 1992 493 498
17. G. Sturm, B. Kranke, C. Rudolph, and W. Aberer Rush Hymenoptera venom immunotherapy: a safe and practical protocol for high-risk patients J Allergy Clin Immunol 110 2002 928 933
18. R. Moverare, E. Vesterinen, T. Metso, R. Sorva, L. Elfman, and T. Haahtela Pollen-specific rush immunotherapy: clinical efficacy and effects on antibody concentrations Ann Allergy Asthma Immunol 86 2001 337 342
19. T.B. Casale Omalizumab: an effective anti-IgE treatment for allergic asthma and rhinitis Drugs Today (Barc) 40 2004 367 376
20. S.T. Holgate, R. Djukanovic, T. Casale, and J. Bousquet Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy Clin Exp Allergy 35 2005 408 416
21. L.A. Beck, G.V. Marcotte, D. MacGlashan, A. Togias, and S. Saini Omalizumab-induced reductions in mast cell Fcepsilon RI expression and function J Allergy Clin Immunol 114 2004 527 530
22. J. Portnoy, K. Bagstad, H. Kanarek, F. Pacheco, B. Hall, and C. Barnes Premedication reduces the incidence of systemic reactions during inhalant rush immunotherapy with mixtures of allergenic extracts Ann Allergy 73 1994 409 418
23. T.B. Casale, J. Condemi, C. LaForce, A. Nayak, M. Rowe, and M. Watrous Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial JAMA 286 2001 2956 2967
24. T.B. Casale Anti-immunoglobulin E (omalizumab) therapy in seasonal allergic rhinitis Am J Respir Crit Care Med 164 2001 S18 S21
25. J. Kuehr, J. Brauburger, S. Zielen, U. Schauer, W. Kamin, and B.A. Von Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis J Allergy Clin Immunol 109 2002 274 280
26. C. Rolinck-Werninghaus, E. Hamelmann, T. Keil, M. Kulig, K. Koetz, and B. Gerstner The co-seasonal application of anti-IgE after preseasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children Allergy 59 2004 973 979
27. K.T. Nouri-Aria, P.A. Wachholz, J.N. Francis, M.R. Jacobson, S.M. Walker, and L.K. Wilcock Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity J Immunol 172 2004 3252 3259
28. P.A. Eigenmann Future therapeutic options in food allergy Allergy 58 2003 1217 1223
29. A. Reimers, Y. Hari, and U. Muller Reduction of side-effects from ultrarush immunotherapy with honeybee venom by pretreatment with fexofenadine: a double-blind, placebo-controlled trial Allergy 55 2000 484 488
30. J. Matuska, M. Bajer, and M. Hrstkova Rush immunotherapy with the standardized grass-pollen extract in children with mild allergic asthma: a comparison of two premedication regimens Scr Med (Brno) 74 2005 367 378
31. P.S. Creticos, D.G. Marsh, D. Proud, A. Kagey-Sobotka, N.F. Adkinson Jr., and L. Friedhoff Responses to ragweed-pollen nasal challenge before and after immunotherapy J Allergy Clin Immunol 84 1989 197 205
32. W. Franklin, and F.C. Lowell Comparison of two dosages of ragweed extract in the treatment of pollenosis JAMA 201 1967 915 917
33. M.J. Furin, P.S. Norman, P.S. Creticos, D. Proud, A. Kagey-Sobotka, and L.M. Lichtenstein Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity J Allergy Clin Immunol 88 1991 27 32
34. L. Haugaard, R. Dahl, and L. Jacobsen A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: clinical efficacy and side effects J Allergy Clin Immunol 91 1993 709 722
35. A.M. Majchel, D. Proud, L. Freidhoff, P.S. Creticos, P.S. Norman, and R.M. Naclerio The nasal response to histamine challenge: effect of the pollen season and immunotherapy J Allergy Clin Immunol 90 1992 85 91